Pulmonary CT angiograms that detect coronary artery calcification can help predict acute coronary syndrome in some patients
Coronary artery calcification (CAC) is a significant predictor of acute coronary syndrome (ACS), particularly among certain groups of patients, according to a study published in the American Journal of Roentgenology.
Researchers from Massachusetts General Hospital and Harvard Medical School sought to evaluate the frequency of unreported CAC and its association with a diagnosis of ACS. To do this, they obtained data from 469 patients who underwent emergency pulmonary CT angiography for suspected pulmonary thromboembolism.
Positive findings for CAC were recorded, all pulmonary CT angiograms were reevaluated by a radiologist and findings of CAC were recorded.
The findings showed that approximately 11.1 percent of the patients who underwent the pulmonary CT angiograms did have a pulmonary thromboembolism and 43.8 percent had CAC. “The incidence of CAC was significantly higher in patients with an ACS diagnosis than without ACS (56.2 percent versus 40.4 percent, respectively),” wrote the authors.
Men who were 45 years old or younger and women 55 years old or younger had a positive association between CAC and ACS, as did those without cardiometabolic factors.
Ninety-eight of the patients (45 percent) had positive CAC, but it had not been reported. ACS was diagnosed in 31.6 percent of patients among whom CAC had not been reported. “There was a significant association between CAC and ACS in patients with unreported CAC,” the researchers noted, with the association being more prominent in the subgroups described.
The researchers concluded that although CAC is often not reported in pulmonary CT angiography studies, it “is a significant predictor of ACS particularly in younger patients, patients without pulmonary thromboembolism, and those without cardiometabolic risk factors.” They recommend that radiologists should assess CAC findings, especially in these subgroups.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
FDA Clears Mobile C-Arm Device that May Accelerate Fluoroscopic and 3D CT Imaging
March 21st 2024Offering ease of mobility and self-driving capabilities, the Ciartic Move C-arm device reportedly reduces the stress and potential for error associated with manual repositioning during intraoperative imaging with computed tomography and fluoroscopy.